๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX ยท Real-Time Price ยท USD
28.34
-1.14 (-3.87%)
At close: Nov 20, 2026, 4:00 PM EST
28.05
-0.29 (-1.02%)
After-hours: Nov 20, 2026, 7:51 PM EST

Definium Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-254.15-166.31-103.92-93.87-66.33-93.55
Net Income
-337.48-183.79-108.68-95.73-56.8-93.04
Earnings Per Share
-2.96-2.06-1.54-2.44-1.84-3.40
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,047411.59273.7499.7142.14133.54
Total Debt
36.6640.5821.8514.13--
Net Cash (Debt)
1,010371.01251.8985.58142.14133.54
Net Cash Growth
501.00%47.29%194.35%-39.80%6.44%66.73%
Net Cash Per Share
8.854.153.572.194.614.88

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-191.36-131.56-79.13-64.37-50.14-45.82
Free Cash Flow
-191.36-131.56-79.13-64.37-50.14-45.82
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.